Clinical Digital Pathology

Our vision is to build a national digital pathology platform capable of holding a digital pathology image for every cancer patient in the NHS, to support both clinical care and research and innovation.

NPIC has created a national digital pathology system for the NHS with the aims of supporting:

  • Full Digitisation of 3 NHS pathology networks in the North of England
  • A national network for children’s cancer
  • A national network for soft tissue and bone tumours (sarcoma)

Over the next 2 years the NPIC network will grow to include over 40 hospitals in the NHS, scanning over 3 million images per year, creating the biggest national digital pathology network in the world.

To find out more about the NPIC Deployment Team, click on the link > NPIC Deployment Team

NPIC Coloured Dots

NPIC Platform Overview

A single Digital Pathology solution has been recognised as key requirement to support clinical pathology services, both regionally and on a national level; enabling better use of pathology data and the creation of innovative, image analysis and artificial intelligence based diagnostic techniques. 

The NPIC programme is underpinned by Information Technology and the delivery of a range of digital solutions. NPIC in partnership with expert industry partners are providing a single national Digital Pathology Solution, providing the infrastructure for a centralised whole slide imaging repository, including a fully hosted secure and stable infrastructure platform and digital PACS (Picture Archive and Communications) System.

NPIC Coloured Dots

Benefits of Joining NPIC

The principal benefits of adopting the National NPIC Digital Pathology Solution can support improving diagnostic workflow, improving workforce factors, improving service quality and financial benefits, with improvement in any one domain likely to contribute to improvement in all other domains:

Clinical Use Cases

  • Faster 2nd opinions for diagnosis, regional and national
  • Retain consultants / Attract new consultants (work-life balance)
  • Improved turnaround time for patient diagnosis
  • Reduction in staff time spent assembling, filing, despatching, retrieving archive cases. Including chasing missing slides, recuts for damaged/missing glass slides
  • Sustainable pathology workforce across the Network  
  • Reduces carbon footprint through reduced travel and transport of glass slides
  • Value of providing improved, more efficient training to NHS histopathologists
  • Instant retrieval of cases digitally vs. 1-14 days for glass slides
  • Reduce costs of recuts due to deteriorated slides / lost slides / broken slides
  • Improved access to second opinions leading to reduction in the costs to NHS of incorrect diagnosis of tumours from chemotherapy use, surgery and litigation
  • Support for national specialist networks (e.g. sarcoma, paediatric, neuropathology, perinatal, transplant
  • National Archive
  • Teaching library functionality
  • Access to pathology reporting pool
  • National worklist to distribute work
  • Facilitating ability to insource and outsource caseloads within the NHS or Private Sector (Future capability)

Artificial Intelligence

  • AI training across multiple sites
  • Accelerate ability to deploy A.I capabilities to ALL the NHS (One Click Deployment)
  • Extract data for AI or research
  • Centralised ML operations team

Costs & Total Costs of Ownership

  • Volume savings on PACS Licencing – Economies of scale
  • Substantial reduction in local infrastructure costs
  • Reduction of spend on outsourcing / locums and overtime to support reporting of patient cases
  • Reduction in costs to transport glass slides within the network
  • Improved workflows and efficiencies for consultants and within the laboratory
  • Reduced financial penalties
  • Reduced litigation costs
  • Improved efficiency of MDTs regionally & nationally
  • Reduction in travel costs due to remote working and remote MDTs